Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.53 |
| ▸ | NT5E | P21589 | 4/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.49 |
| ▸ | AHCY | P23526 | 4/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.40 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.40 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.40 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850184 | 1.00 | BCHE (0.53) | BCHENT5EADORA1AHCYEGFR | |
| SCHEMBL22206323 | 0.87 | NT5E (0.66) | NT5E | |
| SCHEMBL20305252 | 0.87 | NT5E (0.66) | NT5E | |
| SCHEMBL15948772 | 0.86 | PRMT5 (0.41) | BCHENT5EADORA1EGFR | |
| SCHEMBL9850201 | 0.86 | BCHE (0.54) | BCHENT5EADORA1AHCYEGFR | |
| SCHEMBL9850195 | 0.86 | BCHE (0.54) | BCHENT5EADORA1AHCYEGFR | |
| SCHEMBL10436010 | 0.84 | BCHE (0.52) | BCHENT5EADORA1AHCYPI4KA | |
| SCHEMBL10436009 | 0.84 | BCHE (0.52) | BCHENT5EADORA1AHCYPI4KA | |
| SCHEMBL9850171 | 0.82 | NT5E (0.66) | NT5EADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL9850169 | 0.82 | NT5E (0.66) | NT5EADORA1PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0428109-A2 | Deoxyfluoronucleoside process | Bristol-Myers Squibb Company (US) | 1991-05-22 | — | — | EP | disclosed |